Clinigen acquisition of Quantum Pharma approved
Clinigen's acquisition of AIM peer Quantum Pharma, a manufacturer and supplier of unlicensed medicines and special obtain products, was approved on Tuesday.
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Food & Drug Retailers
3,784.33
16:59 23/04/24
-0.20%
-7.50
FTSE AIM 100
3,646.83
17:14 23/04/24
n/a
n/a
FTSE AIM 50
3,997.69
17:14 23/04/24
n/a
n/a
FTSE AIM All-Share
754.87
17:14 23/04/24
n/a
n/a
Cancellation of trading of the Quantum shares on AIM will take place on 2 November.